AR037594A1 - Metodos para tratar infecciones bacterianas en perros y gatos - Google Patents

Metodos para tratar infecciones bacterianas en perros y gatos

Info

Publication number
AR037594A1
AR037594A1 ARP020104593A ARP020104593A AR037594A1 AR 037594 A1 AR037594 A1 AR 037594A1 AR P020104593 A ARP020104593 A AR P020104593A AR P020104593 A ARP020104593 A AR P020104593A AR 037594 A1 AR037594 A1 AR 037594A1
Authority
AR
Argentina
Prior art keywords
cats
bacterial infections
dogs
methods
treat bacterial
Prior art date
Application number
ARP020104593A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0130694.3A external-priority patent/GB0130694D0/en
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of AR037594A1 publication Critical patent/AR037594A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
ARP020104593A 2001-12-21 2002-11-28 Metodos para tratar infecciones bacterianas en perros y gatos AR037594A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0130694.3A GB0130694D0 (en) 2001-12-21 2001-12-21 Treatment
US35996102P 2002-02-27 2002-02-27
US39893302P 2002-07-26 2002-07-26

Publications (1)

Publication Number Publication Date
AR037594A1 true AR037594A1 (es) 2004-11-17

Family

ID=27256361

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020104593A AR037594A1 (es) 2001-12-21 2002-11-28 Metodos para tratar infecciones bacterianas en perros y gatos

Country Status (12)

Country Link
EP (1) EP1455900A1 (pl)
JP (1) JP2005524611A (pl)
CN (1) CN1606463A (pl)
AR (1) AR037594A1 (pl)
AU (1) AU2002348985A1 (pl)
BR (1) BR0215070A (pl)
CA (1) CA2470995A1 (pl)
IL (1) IL162103A0 (pl)
NO (1) NO20043008L (pl)
PL (1) PL370624A1 (pl)
TW (1) TW200301126A (pl)
WO (1) WO2003053522A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007533724A (ja) * 2004-04-22 2007-11-22 ファイザー・プロダクツ・インク 無秩序なセフォベシンナトリウム塩を安定させる方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0395219T3 (da) * 1989-03-30 1999-02-15 Pfizer Cephalosporiner og deres homologer, fremgangsmåde til deres fremstilling og farmaceutiske præparater
GB9424847D0 (en) * 1994-12-09 1995-02-08 Smithkline Beecham Plc Novel process
GB2300856A (en) * 1995-05-16 1996-11-20 Pfizer Ltd Beta-lactam preparation

Also Published As

Publication number Publication date
PL370624A1 (pl) 2005-05-30
AU2002348985A1 (en) 2003-07-09
NO20043008L (no) 2004-09-01
WO2003053522A1 (en) 2003-07-03
JP2005524611A (ja) 2005-08-18
TW200301126A (en) 2003-07-01
CA2470995A1 (en) 2003-07-03
BR0215070A (pt) 2004-11-09
IL162103A0 (en) 2005-11-20
EP1455900A1 (en) 2004-09-15
CN1606463A (zh) 2005-04-13

Similar Documents

Publication Publication Date Title
AR037595A1 (es) Metodos de tratamiento y formulaciones de cefalosporina
EA199901015A1 (ru) 4"-замещенные производные 9-деоксо-9а-а3а-9а-гомоэритромицина а
BR0214736A (pt) Composto e seus sais farmaceuticamente aceitáveis, composição farmacêutica e método de tratar seres humanos ou animais que sofrem de doenças ou condições
BR9915208A (pt) Preparado farmacêutico de moxifloxacina
EA200400701A1 (ru) 13-членные азалиды и их применение в качестве антибиотических агентов
EA200100623A1 (ru) Кетолидные антибиотики
DK0694545T3 (da) Substituerede dibenzoxazepinforbindelser, farmaceutiske sammensætninger og anvendelsesmetoder
ATE496048T1 (de) Phenylcarboxamidverbindungen zur schmerzbehandlung
BR9808290A (pt) Composto, composição farmacêutica, processo de tratar infecções bacterianas em seres humanos e animais, uso de um composto, e, processo para sua preparação
RU94008616A (ru) 2-тиозамещенные карбапенемы, промежуточные соединения для получения, способы получения, фармацевтическая композиция, способ лечения бактериальных инфекций
ATE268337T1 (de) C11-carbamate von antibakteriellen makroliden
NO923200D0 (no) Piperidin-derivater
BR0015722A (pt) Uso de derivados de pleuromutilina para tratamento transdérmico de doenças bacterianas
CA2288341A1 (en) Erythropoietin in the treatment of domestic and livestock animals for anemia
BR0006301A (pt) Macrólidos antibacterianos e pró-cinéticos
EA200001029A1 (ru) Производные гигромицина
AR037594A1 (es) Metodos para tratar infecciones bacterianas en perros y gatos
KR890003378A (ko) 혐기성균에 대해 항균작용을 갖는 나프티리딘 화합물
BR9915639A (pt) Uso de derivados de ácido fosfonofórmico para o tratamento de infecções
ID22543A (id) Senyawa karbapenem, penggunaan dan senyawa antaranya
DE3775823D1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
BR0308118A (pt) Método para o tratamento de osteoartrite
DE69935988D1 (de) Zuchtmethode und futtermittel
GB0003234D0 (en) Method of treatment
BR9814815A (pt) Agente para o tratamento de leishmaniose com um derivado de glicopiranose como ingrediente eficaz

Legal Events

Date Code Title Description
FB Suspension of granting procedure